The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
Lee A, Patrick P, Wishart J, Horowitz M, Morley JE.
Lee A, et al.
Diabetes Obes Metab. 2002 Sep;4(5):329-35. doi: 10.1046/j.1463-1326.2002.00219.x.
Diabetes Obes Metab. 2002.
PMID: 12190996
Clinical Trial.
Little is known about the postprandial release of GLP-1 after AGI therapy in diabetics. GLP-1 plays a role to mediate satiety. Any agent that substantially elevates GLP-1 levels may theoretically reduce hunger, increase satiation and limit food intake. ...Correspond …
Little is known about the postprandial release of GLP-1 after AGI therapy in diabetics. GLP-1 plays a role to mediate satiety. Any ag …